![Zachary Roberts](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: 386 104 $ in data 31/08/2026
Zachary Roberts is currently President, Chief Executive Officer & Director at Allogene Therapeutics, Inc., starting in 2026.
Formerly, Dr. Roberts was Chief Medical Officer at Instil Bio, Inc. from 2020 to 2022, Vice President-Clinical Development at Kite Pharma, Inc. from 2018 to 2019, and Director-Clinical Medical Research at Amgen, Inc. in 2015.
Education includes undergraduate studies at the University of Maryland and a doctorate from the University of Maryland School of Medicine.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 01/07/2026 | 193.052 ( 0,06% ) | 386 104 $ | 31/08/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| ALLOGENE THERAPEUTICS, INC. | Amministratore Delegato | 01/07/2026 |
| Società | Posizione | Fine |
|---|---|---|
| INSTIL BIO, INC. | Direttore Tecnico/Scientifico/R&S | 11/11/2022 |
| KITE PHARMA INC | Direttore Tecnico/Scientifico/R&S | 01/05/2019 |
| AMGEN INC. | Direttore Tecnico/Scientifico/R&S | 01/07/2015 |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 6 |
|---|---|
Amgen, Inc.
 Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
University of Maryland
 University of Maryland Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Maryland School of Medicine
 University of Maryland School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kite Pharma, Inc.
 Kite Pharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biotechnology company which engages in the development of novel cancer immunotherapeutic products | Health Technology |
Allogene Therapeutics, Inc.
 Allogene Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage immuno-oncology | Health Technology |
Instil Bio, Inc.
 Instil Bio, Inc. BiotechnologyHealth Technology Develops tumour infiltrating lymphocytes for the treatment of cancer | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
